Ignite Creation Date:
2025-12-24 @ 5:33 PM
Ignite Modification Date:
2026-01-02 @ 10:22 AM
Study NCT ID:
NCT02773368
Status:
COMPLETED
Last Update Posted:
2020-08-11
First Post:
2016-05-13
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Clinical Trial Comparing Glycaemic Control and Safety of Insulin Degludec/Liraglutide (IDegLira) Versus Insulin Glargine (IGlar) as add-on Therapy to SGLT2i in Subjects With Type 2 Diabetes Mellitus
Sponsor:
Novo Nordisk A/S
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2016-05-23
Start Date Type:
ACTUAL
Primary Completion Date:
2017-09-26
Primary Completion Date Type:
ACTUAL
Completion Date:
2017-10-23
Completion Date Type:
ACTUAL
First Submit Date:
2016-05-13
First Submit QC Date:
None
Study First Post Date:
2016-05-16
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2018-09-24
Results First Submit QC Date:
None
Results First Post Date:
2018-10-23
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2020-08-10
Last Update Post Date:
2020-08-11
Last Update Post Date Type:
ACTUAL